Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

MOHAMMADBAGHER ZIARI

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1962601047
CMS profile
271171
Location
CORONA, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2021 · Entire year

$482,263.59

368 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2021 · entire year · sorted by reported total

By paying entity

PY2021 · entire year · sorted by reported total

Paying entityAmountRecords
Karyopharm Therapeutics Inc. $159,953.07 104
AstraZeneca Pharmaceuticals LP $137,117.52 97
E.R. Squibb & Sons, L.L.C. $51,579.38 31
Amgen Inc. $36,247.80 41
Daiichi Sankyo Inc. $27,339.25 28
GENZYME CORPORATION $25,289.49 20
AbbVie Inc. $15,687.10 13
Regeneron Healthcare Solutions, Inc. $9,703.98 6
Celgene Corporation $4,869.75 7
Taiho Oncology, Inc. $4,787.50 3
Servier Pharmaceuticals LLC $3,785.59 4
Agios Pharmaceuticals, Inc. $2,450.00 2
Eisai Inc. $1,620.00 1
TG THERAPEUTICS, INC. $945.49 2
Incyte Corporation $374.48 3
GlaxoSmithKline, LLC. $123.92 1
JAZZ PHARMACEUTICALS INC. $119.47 1
Lilly USA, LLC $119.26 1
Janssen Biotech, Inc. $98.95 1
PUMA BIOTECHNOLOGY, INC. $39.67 1
Gilead Sciences, Inc. $11.92 1

Page 5 of 8; records 201–250 of 368 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

MOHAMMADBAGHER ZIARI

NPI 1962601047 · CMS profile ID 271171

Allopathic & Osteopathic Physicians / Internal Medicine / Hematology & Oncology

CORONA, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 5 of 8; records 201–250 of 368 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1962601047?year=2021&recipient=provider&page=5#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
MOHAMMADBAGHER ZIARI, NPI 1962601047, CMS profile ID 271171. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 5 of 8; records 201–250 of 368 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1962601047?year=2021&recipient=provider&page=5#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
APA 7
IndustryPayments. (2026). MOHAMMADBAGHER ZIARI, NPI 1962601047, CMS profile ID 271171. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 5 of 8; records 201–250 of 368 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1962601047?year=2021&recipient=provider&page=5#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
Bluebook
MOHAMMADBAGHER ZIARI, NPI 1962601047, CMS profile ID 271171, IndustryPayments, General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 5 of 8; records 201–250 of 368 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202. https://industrypayments.org/provider/npi-1962601047?year=2021&recipient=provider&page=5#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2021 · Physicians and non-physician practitioners · CMS publication 2026-06-30

368 matching records · $482,263.59 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 368 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 201–250 of 368.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Karyopharm Therapeutics Inc. $10.2506/25/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 845787209 CMS
Karyopharm Therapeutics Inc. $5,688.0006/25/2021 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 845787261 CMS
Karyopharm Therapeutics Inc. $360.0006/25/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 845787383 CMS
AstraZeneca Pharmaceuticals LP $124.4106/24/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829822051 CMS
AstraZeneca Pharmaceuticals LP $365.0006/24/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829851061 CMS
Karyopharm Therapeutics Inc. $1,940.0006/24/2021 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 845787227 CMS
AstraZeneca Pharmaceuticals LP $450.0006/22/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829749333 CMS
E.R. Squibb & Sons, L.L.C. $3,665.0006/22/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783557887 CMS
GENZYME CORPORATION $116.8706/22/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 843589817 CMS
GENZYME CORPORATION $3,255.0006/22/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 843589819 CMS
GENZYME CORPORATION $745.4106/22/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 843589821 CMS
Celgene Corporation $324.0006/17/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 853635273 CMS
Celgene Corporation $3,005.0006/17/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 853635277 CMS
Celgene Corporation $125.0006/17/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 853635281 CMS
Daiichi Sankyo Inc. $900.0006/17/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 836295207 CMS
Amgen Inc. $1,125.0006/16/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 826397347 CMS
Servier Pharmaceuticals LLC $1,410.0006/16/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 852925289 CMS
Amgen Inc. $98.7706/15/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 825636099 CMS
E.R. Squibb & Sons, L.L.C. $340.0006/15/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783557891 CMS
AbbVie Inc. $2,750.0006/14/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 796306783 CMS
AbbVie Inc. $220.0006/10/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 796306781 CMS
E.R. Squibb & Sons, L.L.C. $120.4406/10/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783557889 CMS
GENZYME CORPORATION $19.4806/10/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 843589823 CMS
GENZYME CORPORATION $2,604.0006/10/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 843589825 CMS
GENZYME CORPORATION $336.0006/10/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 843589827 CMS
AstraZeneca Pharmaceuticals LP $3,350.0006/08/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829866159 CMS
E.R. Squibb & Sons, L.L.C. $4,505.0006/08/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783557873 CMS
AbbVie Inc. $26.7906/07/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 796306779 CMS
Daiichi Sankyo Inc. $4,450.0006/07/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 836295351 CMS
Karyopharm Therapeutics Inc. $16.8906/04/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 845787235 CMS
Karyopharm Therapeutics Inc. $490.0006/04/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 845787271 CMS
Karyopharm Therapeutics Inc. $5,688.0006/04/2021 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 845787371 CMS
AbbVie Inc. $1,650.0006/02/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 796306777 CMS
Daiichi Sankyo Inc. $102.7306/02/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 836302701 CMS
Daiichi Sankyo Inc. $373.9606/02/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 836303139 CMS
Daiichi Sankyo Inc. $616.7606/02/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 836303167 CMS
AstraZeneca Pharmaceuticals LP $330.0006/01/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829330763 CMS
AstraZeneca Pharmaceuticals LP $1,110.0006/01/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829621975 CMS
AstraZeneca Pharmaceuticals LP $124.5506/01/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 830090443 CMS
Gilead Sciences, Inc. $11.9206/01/2021 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 845881231 CMS
Daiichi Sankyo Inc. $4,450.0005/31/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 836287859 CMS
AstraZeneca Pharmaceuticals LP $1,100.0005/30/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829962041 CMS
AstraZeneca Pharmaceuticals LP $1,100.0005/30/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 830062647 CMS
AstraZeneca Pharmaceuticals LP $2,200.0005/30/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 830218519 CMS
Karyopharm Therapeutics Inc. $280.0005/28/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 845787257 CMS
Karyopharm Therapeutics Inc. $4,063.0005/28/2021 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 845787283 CMS
Karyopharm Therapeutics Inc. $10.8205/28/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 845787335 CMS
AstraZeneca Pharmaceuticals LP $3,900.0005/27/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829973663 CMS
AstraZeneca Pharmaceuticals LP $4,450.0005/26/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829587789 CMS
E.R. Squibb & Sons, L.L.C. $86.9305/26/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783557871 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $264,541.35 325
PY2020 $220,023.17 253
PY2021 $482,263.59 368
PY2022 $495,492.09 406
PY2023 $428,531.95 359
PY2024 $282,331.25 272
PY2025 $291,443.81 226

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2020 Principal investigator $290.00 4
PY2019 Principal investigator $741.50 5

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2020

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

4 records in PY2020

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Merck Sharp & Dohme Corporation $100.00 11/24/2020 Covered Recipient Teaching Hospital
CITY OF HOPE NATIONAL MEDICAL CTR
A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of MK-3475 as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer with 1 cm Residual Invasive Cancer or Positive Lymph Nodes pN1mic After Neoadjuvant Chemotherapy No dispute reported 06/30/2026 740831327
Principal investigator 1 Merck Sharp & Dohme Corporation $100.00 11/24/2020 Covered Recipient Teaching Hospital
CITY OF HOPE NATIONAL MEDICAL CTR
A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of MK-3475 as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer with 1 cm Residual Invasive Cancer or Positive Lymph Nodes pN1mic After Neoadjuvant Chemotherapy No dispute reported 06/30/2026 740831329
Principal investigator 1 Merck Sharp & Dohme Corporation $30.00 07/29/2020 Covered Recipient Teaching Hospital
CITY OF HOPE NATIONAL MEDICAL CTR
A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of MK-3475 as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer with 1 cm Residual Invasive Cancer or Positive Lymph Nodes pN1mic After Neoadjuvant Chemotherapy No dispute reported 06/30/2026 740830957
Principal investigator 1 Merck Sharp & Dohme Corporation $60.00 07/29/2020 Covered Recipient Teaching Hospital
CITY OF HOPE NATIONAL MEDICAL CTR
A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of MK-3475 as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer with 1 cm Residual Invasive Cancer or Positive Lymph Nodes pN1mic After Neoadjuvant Chemotherapy No dispute reported 06/30/2026 740831877